Literature DB >> 20375354

The changing microbial epidemiology in cystic fibrosis.

John J Lipuma1.   

Abstract

Infection of the airways remains the primary cause of morbidity and mortality in persons with cystic fibrosis (CF). This review describes salient features of the epidemiologies of microbial species that are involved in respiratory tract infection in CF. The apparently expanding spectrum of species causing infection in CF and recent changes in the incidences and prevalences of infection due to specific bacterial, fungal, and viral species are described. The challenges inherent in tracking and interpreting rates of infection in this patient population are discussed.

Entities:  

Mesh:

Year:  2010        PMID: 20375354      PMCID: PMC2863368          DOI: 10.1128/CMR.00068-09

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  348 in total

1.  Staphylococcal cassette chromosome mec and Panton-Valentine leukocidin characterization of methicillin-resistant Staphylococcus aureus clones.

Authors:  Shannon M Moroney; Loree C Heller; Jesse Arbuckle; Monica Talavera; Ray H Widen
Journal:  J Clin Microbiol       Date:  2006-12-27       Impact factor: 5.948

2.  A comparison of methods of phenotypic and genotypic fingerprinting of Exophiala dermatitidis isolated from sputum samples of patients with cystic fibrosis.

Authors:  P M Rath; K D Müller; H Dermoumi; R Ansorg
Journal:  J Med Microbiol       Date:  1997-09       Impact factor: 2.472

3.  Risk factors for allergic bronchopulmonary aspergillosis and sensitisation to Aspergillus fumigatus in patients with cystic fibrosis.

Authors:  Nicole Ritz; Roland A Ammann; Carmen Casaulta Aebischer; Franziska Schoeni-Affolter; Martin H Schoeni
Journal:  Eur J Pediatr       Date:  2005-05-31       Impact factor: 3.183

4.  Differentiation of Burkholderia species by PCR-restriction fragment length polymorphism analysis of the 16S rRNA gene and application to cystic fibrosis isolates.

Authors:  C Segonds; T Heulin; N Marty; G Chabanon
Journal:  J Clin Microbiol       Date:  1999-07       Impact factor: 5.948

5.  The general secretory pathway of Burkholderia gladioli pv. agaricicola BG164R is necessary for cavity disease in white button mushrooms.

Authors:  Piklu Roy Chowdhury; Jack A Heinemann
Journal:  Appl Environ Microbiol       Date:  2006-05       Impact factor: 4.792

6.  Stenotrophomonas maltophilia contamination of nebulizers used to deliver aerosolized therapy to inpatients with cystic fibrosis.

Authors:  M Denton; A Rajgopal; L Mooney; A Qureshi; K G Kerr; V Keer; K Pollard; D G Peckham; S P Conway
Journal:  J Hosp Infect       Date:  2003-11       Impact factor: 3.926

7.  Typing of Staphylococcus aureus by pulsed-field gel electrophoresis, zymotyping, capsular typing, and phage typing: resolution of clonal relationships.

Authors:  C Schlichting; C Branger; J M Fournier; W Witte; A Boutonnier; C Wolz; P Goullet; G Döring
Journal:  J Clin Microbiol       Date:  1993-02       Impact factor: 5.948

8.  Recovery of Pseudomonas cepacia and other Pseudomonas species from the environment.

Authors:  J E Mortensen; M C Fisher; J J LiPuma
Journal:  Infect Control Hosp Epidemiol       Date:  1995-01       Impact factor: 3.254

9.  Epidemiology of Burkholderia cepacia complex in patients with cystic fibrosis, Canada.

Authors:  David P Speert; Deborah Henry; Peter Vandamme; Mary Corey; Eshwar Mahenthiralingam
Journal:  Emerg Infect Dis       Date:  2002-02       Impact factor: 6.883

Review 10.  Viral respiratory infections in cystic fibrosis.

Authors:  Bart E van Ewijk; Marieke M van der Zalm; Tom F W Wolfs; Cornelis K van der Ent
Journal:  J Cyst Fibros       Date:  2005-08       Impact factor: 5.482

View more
  317 in total

1.  A new highly discriminatory multiplex capillary-based MLVA assay as a tool for the epidemiological survey of Pseudomonas aeruginosa in cystic fibrosis patients.

Authors:  D Sobral; P Mariani-Kurkdjian; E Bingen; H Vu-Thien; K Hormigos; B Lebeau; F Loisy-Hamon; A Munck; G Vergnaud; C Pourcel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-02-11       Impact factor: 3.267

Review 2.  Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria.

Authors:  Barbara A Brown-Elliott; Kevin A Nash; Richard J Wallace
Journal:  Clin Microbiol Rev       Date:  2012-07       Impact factor: 26.132

3.  Pseudomonas aeruginosa Inhibits the Growth of Scedosporium and Lomentospora In Vitro.

Authors:  Sharon C-A Chen; Shilpa Patel; Wieland Meyer; Belinda Chapman; Hong Yu; Karen Byth; Peter G Middleton; Helena Nevalainen; Tania C Sorrell
Journal:  Mycopathologia       Date:  2017-05-16       Impact factor: 2.574

4.  Evolutionary genomics of epidemic and nonepidemic strains of Pseudomonas aeruginosa.

Authors:  Jeremy R Dettman; Nicolas Rodrigue; Shawn D Aaron; Rees Kassen
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-09       Impact factor: 11.205

Review 5.  Regulation of Virulence by Two-Component Systems in Pathogenic Burkholderia.

Authors:  Matthew M Schaefers
Journal:  Infect Immun       Date:  2020-06-22       Impact factor: 3.441

Review 6.  Non-tuberculous Mycobacterial Infections in Thoracic Transplant Candidates and Recipients.

Authors:  Mana Rao; Fernanda P Silveira
Journal:  Curr Infect Dis Rep       Date:  2018-05-12       Impact factor: 3.725

Review 7.  Burkholderia cepacia Complex Bacteria: a Feared Contamination Risk in Water-Based Pharmaceutical Products.

Authors:  Mariana Tavares; Mariya Kozak; Alexandra Balola; Isabel Sá-Correia
Journal:  Clin Microbiol Rev       Date:  2020-04-15       Impact factor: 26.132

8.  Developing an international Pseudomonas aeruginosa reference panel.

Authors:  Anthony De Soyza; Amanda J Hall; Eshwar Mahenthiralingam; Pavel Drevinek; Wieslaw Kaca; Zuzanna Drulis-Kawa; Stoyanka R Stoitsova; Veronika Toth; Tom Coenye; James E A Zlosnik; Jane L Burns; Isabel Sá-Correia; Daniel De Vos; Jean-Paul Pirnay; Timothy J Kidd; David Reid; Jim Manos; Jens Klockgether; Lutz Wiehlmann; Burkhard Tümmler; Siobhán McClean; Craig Winstanley
Journal:  Microbiologyopen       Date:  2013-11-11       Impact factor: 3.139

9.  Factors influencing acquisition of Burkholderia cepacia complex organisms in patients with cystic fibrosis.

Authors:  Kay A Ramsay; Claire A Butler; Stuart Paynter; Robert S Ware; Timothy J Kidd; Claire E Wainwright; Scott C Bell
Journal:  J Clin Microbiol       Date:  2013-09-18       Impact factor: 5.948

10.  Bacterial defenses against a natural antibiotic promote collateral resilience to clinical antibiotics.

Authors:  Lucas A Meirelles; Elena K Perry; Megan Bergkessel; Dianne K Newman
Journal:  PLoS Biol       Date:  2021-03-10       Impact factor: 8.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.